Sky Investment Group LLC Amgen Inc Transaction History

Sky Investment Group LLC

$536 Million
Q3 2024

A detailed history of Sky Investment Group LLC transactions in Amgen Inc stock. As of the latest transaction made, Sky Investment Group LLC holds 2,173 shares of AMGN stock, worth $693,817. This represents 0.13% of its overall portfolio holdings.

Number of Shares

2,173

Previous 2,263 3.98%

Holding current value

$693,817

Previous $707,000 0.99%

% of portfolio

0.13%

Previous 0.14%

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 21, 2024	SELL	$309.38 - $337.38 $27,844 - $30,364	-90 Reduced 3.98%	2,173 $700,000
Q2 2024 Jul 16, 2024	SELL	$262.75 - $319.31 $10,510 - $12,772	-40 Reduced 1.74%	2,263 $707,000
Q2 2023 Jul 25, 2023	SELL	$214.27 - $253.37 $16,284 - $19,256	-76 Reduced 3.19%	2,303 $511,000
Q3 2022 Oct 25, 2022	BUY	$224.46 - $253.15 $13,467 - $15,189	60 Added 2.59%	2,379 $536,000
Q2 2022 Jul 12, 2022	BUY	$230.71 - $256.74 $40,604 - $45,186	176 Added 8.21%	2,319 $564,000
Q1 2022 Apr 14, 2022	SELL	$219.27 - $242.57 $222,559 - $246,208	-1,015 Reduced 32.14%	2,143 $518,000
Q4 2021 Jan 24, 2022	SELL	$198.88 - $227.6 $9,944 - $11,380	-50 Reduced 1.56%	3,158 $710,000
Q3 2021 Nov 08, 2021	SELL	$212.27 - $248.7 $21,227 - $24,870	-100 Reduced 3.02%	3,208 $682,000
Q2 2021 Jul 21, 2021	SELL	$233.58 - $259.14 $16,350 - $18,139	-70 Reduced 2.07%	3,308 $806,000
Q1 2021 Apr 20, 2021	BUY	$221.91 - $258.6 $9,764 - $11,378	44 Added 1.32%	3,378 $840,000
Q4 2020 Jan 25, 2021	BUY	$216.38 - $257.67 $44,574 - $53,080	206 Added 6.59%	3,334 $767,000
Q3 2020 Oct 08, 2020	BUY	$234.65 - $260.95 $733,985 - $816,251	3,128 New	3,128 $795,000

Others Institutions Holding AMGN

# of Institutions

3,090

Shares Held

417M

Call Options Held

7.19M

Put Options Held

6.13M

View Full List

About AMGEN INC

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $171B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

More about AMGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Sky Investment Group LLC, based on Form 13F filings with the SEC.

News

Stay updated on Sky Investment Group LLC with notifications on news.

Account

Sky Investment Group LLC Amgen Inc Transaction History